Virtual Care + RAM for Post-Surgery Complications
(PVC-RAM-2 Trial)
Trial Summary
What is the purpose of this trial?
The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology-2 (PVC-RAM-2) Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on acute-hospital care during the 45-day follow up after randomization, in adults who have undergone semi-urgent (e.g., oncology), urgent (e.g., hip fracture), or emergency (e.g., ruptured abdominal aortic aneurysm) surgery. Secondary outcomes at 45 days after randomization include 1) days in hospital; 2) index length of hospital stay; 3) hospital re-admission; 4) emergency department visit; 5) medication error detection; 6) medication error correction; and 7) surgical site infection. Additional secondary outcomes are pain of any severity, and moderate-to-severe pain assessed at 15 and 45 days. We will also assess optimal management of long-term health by evaluating among self-reported current smokers and those with atherosclerotic disease, whether patients are taking classes of efficacious medications at 45 days post randomization.
Is Virtual Care with Remote Automated Monitoring (RAM) safe for humans?
The studies suggest that Virtual Care with Remote Automated Monitoring (RAM) is generally safe for humans, as it involves monitoring vital signs like heart rate and oxygen levels to quickly detect any issues. However, the technology's effectiveness and safety can depend on proper implementation and use.1234
How is the Virtual Care + RAM treatment different from other treatments for post-surgery complications?
The Virtual Care + RAM treatment is unique because it uses remote automated monitoring (RAM) technology to continuously track multiple health parameters like oxygen levels and heart rate from home, allowing for early detection of complications and timely medical response, unlike traditional care which relies on in-person visits.12356
Research Team
Sandra Ofori, M.D., PhD
Principal Investigator
Hamilton Health Sciences, Population Health Research Institute
Michael McGillion, PhD
Principal Investigator
McMaster University, Population Health Research Institute
PJ Devereaux, M.D, PhD
Principal Investigator
McMaster University, Population Health Research Institute
Eligibility Criteria
This trial is for adults over 40 who've had semi-urgent, urgent, or emergency surgery and are being discharged. They must be able to use a tablet computer for communication and surveys without cognitive, visual, or hearing issues. Those in rehab more than 7 days post-surgery or living without cell coverage can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive virtual care with remote automated monitoring (RAM) technology for 14 days after index hospital discharge, including biophysical measurements and daily recovery surveys.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with a focus on acute-hospital care and secondary outcomes over a 45-day period.
Extension
Two 7-day extensions to the intervention are possible based on the patient's need for continued support.
Treatment Details
Interventions
- Virtual care with remote automated monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
Population Health Research Institute
Lead Sponsor